 Angela Pierce
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor Protein-Tyrosine Kinases | 5 | 2016 | 221 | 1.170 |
Why?
| | Infratentorial Neoplasms | 2 | 2024 | 60 | 0.850 |
Why?
| | Ependymoma | 2 | 2024 | 176 | 0.760 |
Why?
| | Brain Neoplasms | 5 | 2024 | 1149 | 0.720 |
Why?
| | Cerebellar Neoplasms | 4 | 2023 | 155 | 0.660 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2019 | 70 | 0.650 |
Why?
| | Medulloblastoma | 4 | 2023 | 197 | 0.650 |
Why?
| | Glioblastoma | 4 | 2016 | 320 | 0.650 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 209 | 0.600 |
Why?
| | Reproduction | 2 | 2011 | 201 | 0.590 |
Why?
| | Proto-Oncogene Proteins | 6 | 2022 | 634 | 0.580 |
Why?
| | Glioma | 4 | 2024 | 352 | 0.480 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2020 | 430 | 0.470 |
Why?
| | Transplantation, Heterologous | 1 | 2014 | 187 | 0.450 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 258 | 0.450 |
Why?
| | Carcinogenesis | 1 | 2013 | 209 | 0.380 |
Why?
| | Central Nervous System | 1 | 2013 | 255 | 0.370 |
Why?
| | Cell Line, Tumor | 13 | 2024 | 3160 | 0.370 |
Why?
| | Estrous Cycle | 1 | 2011 | 21 | 0.370 |
Why?
| | Gonadotropin-Releasing Hormone | 2 | 2011 | 207 | 0.350 |
Why?
| | Pituitary Gland | 1 | 2011 | 148 | 0.350 |
Why?
| | Hypothalamus | 1 | 2011 | 144 | 0.340 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3943 | 0.330 |
Why?
| | Rhabdoid Tumor | 2 | 2022 | 86 | 0.320 |
Why?
| | Ovary | 1 | 2011 | 214 | 0.320 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1333 | 0.320 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 580 | 0.310 |
Why?
| | Oncogene Proteins | 1 | 2008 | 52 | 0.300 |
Why?
| | Neurons | 3 | 2014 | 1448 | 0.280 |
Why?
| | Apoptosis | 6 | 2024 | 2437 | 0.260 |
Why?
| | Cell Proliferation | 7 | 2022 | 2335 | 0.240 |
Why?
| | Mice | 13 | 2024 | 16579 | 0.240 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2024 | 810 | 0.240 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2024 | 29 | 0.230 |
Why?
| | DNA Repair | 2 | 2024 | 205 | 0.210 |
Why?
| | Animals | 16 | 2024 | 34501 | 0.210 |
Why?
| | Antineoplastic Agents | 4 | 2022 | 2058 | 0.200 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2016 | 371 | 0.200 |
Why?
| | CDC2 Protein Kinase | 1 | 2002 | 31 | 0.200 |
Why?
| | DNA, Fungal | 1 | 2002 | 73 | 0.190 |
Why?
| | Teratoma | 2 | 2022 | 103 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 61 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2021 | 129 | 0.190 |
Why?
| | Radiation Tolerance | 1 | 2022 | 97 | 0.180 |
Why?
| | DNA Replication | 1 | 2002 | 224 | 0.170 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 47 | 0.170 |
Why?
| | Pyrazoles | 2 | 2022 | 400 | 0.170 |
Why?
| | Genes, myc | 1 | 2020 | 50 | 0.170 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 36 | 0.170 |
Why?
| | Mice, Nude | 3 | 2019 | 682 | 0.160 |
Why?
| | Protein Kinase Inhibitors | 2 | 2016 | 872 | 0.160 |
Why?
| | Pyrimidinones | 1 | 2020 | 102 | 0.160 |
Why?
| | SMARCB1 Protein | 1 | 2019 | 18 | 0.160 |
Why?
| | Deoxycytidine | 1 | 2020 | 164 | 0.160 |
Why?
| | Mice, SCID | 1 | 2019 | 345 | 0.160 |
Why?
| | Cellular Senescence | 2 | 2019 | 173 | 0.150 |
Why?
| | Piperazines | 2 | 2022 | 334 | 0.150 |
Why?
| | c-Mer Tyrosine Kinase | 3 | 2016 | 44 | 0.150 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2002 | 375 | 0.150 |
Why?
| | DNA-Binding Proteins | 2 | 2004 | 1415 | 0.150 |
Why?
| | Histones | 2 | 2020 | 581 | 0.150 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 582 | 0.150 |
Why?
| | Saccharomyces cerevisiae | 1 | 2002 | 522 | 0.150 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 927 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 507 | 0.140 |
Why?
| | Polyploidy | 1 | 2016 | 18 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2019 | 325 | 0.130 |
Why?
| | Mice, Knockout | 3 | 2014 | 2752 | 0.120 |
Why?
| | Survival Rate | 1 | 2019 | 1872 | 0.120 |
Why?
| | Cell Death | 1 | 2016 | 348 | 0.120 |
Why?
| | Pentacyclic Triterpenes | 1 | 2014 | 15 | 0.120 |
Why?
| | Adenine | 1 | 2016 | 255 | 0.120 |
Why?
| | Nuclear Proteins | 3 | 2023 | 648 | 0.120 |
Why?
| | Sexual Maturation | 1 | 2014 | 52 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 101 | 0.110 |
Why?
| | Anilides | 1 | 2014 | 72 | 0.110 |
Why?
| | Humans | 18 | 2024 | 128524 | 0.110 |
Why?
| | Quinolines | 1 | 2014 | 149 | 0.100 |
Why?
| | Vagina | 1 | 2014 | 175 | 0.100 |
Why?
| | Chromatin | 3 | 2020 | 478 | 0.100 |
Why?
| | Cell Movement | 3 | 2014 | 937 | 0.100 |
Why?
| | Superovulation | 1 | 2011 | 8 | 0.090 |
Why?
| | Child | 5 | 2024 | 20721 | 0.090 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2011 | 10 | 0.090 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 80 | 0.090 |
Why?
| | Feedback, Physiological | 1 | 2011 | 74 | 0.090 |
Why?
| | Chorionic Gonadotropin | 1 | 2011 | 80 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2014 | 571 | 0.090 |
Why?
| | Ovariectomy | 1 | 2011 | 139 | 0.090 |
Why?
| | Luteinizing Hormone | 1 | 2011 | 178 | 0.090 |
Why?
| | Cell Cycle | 2 | 2004 | 581 | 0.090 |
Why?
| | Aging | 1 | 2020 | 1770 | 0.090 |
Why?
| | Follicle Stimulating Hormone | 1 | 2011 | 239 | 0.080 |
Why?
| | Epigenomics | 2 | 2020 | 111 | 0.080 |
Why?
| | Periodontal Ligament | 1 | 2009 | 3 | 0.080 |
Why?
| | Cell Survival | 2 | 2014 | 1077 | 0.080 |
Why?
| | Tooth Movement Techniques | 1 | 2009 | 12 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 5257 | 0.080 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2009 | 16 | 0.080 |
Why?
| | Nerve Growth Factor | 1 | 2009 | 27 | 0.080 |
Why?
| | Estrus | 1 | 2008 | 12 | 0.080 |
Why?
| | Prosencephalon | 1 | 2008 | 45 | 0.080 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2008 | 178 | 0.070 |
Why?
| | Models, Neurological | 1 | 2008 | 235 | 0.070 |
Why?
| | Female | 7 | 2020 | 68127 | 0.070 |
Why?
| | Nerve Net | 1 | 2008 | 255 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 957 | 0.060 |
Why?
| | Base Sequence | 1 | 2008 | 2134 | 0.060 |
Why?
| | Chromosomes | 1 | 2024 | 101 | 0.050 |
Why?
| | Signal Transduction | 2 | 2014 | 4829 | 0.050 |
Why?
| | Fluorouracil | 1 | 2024 | 197 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 216 | 0.050 |
Why?
| | Cell Line | 1 | 2008 | 2731 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 160 | 0.050 |
Why?
| | Cyclin B | 1 | 2002 | 15 | 0.050 |
Why?
| | Replication Origin | 1 | 2002 | 17 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 45 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 75 | 0.050 |
Why?
| | S Phase | 1 | 2002 | 73 | 0.050 |
Why?
| | G1 Phase | 1 | 2002 | 71 | 0.050 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2002 | 69 | 0.050 |
Why?
| | Nicotine | 1 | 2004 | 303 | 0.050 |
Why?
| | Male | 5 | 2020 | 62883 | 0.050 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2002 | 48 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 235 | 0.050 |
Why?
| | RNA Polymerase II | 1 | 2024 | 313 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 425 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 242 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 215 | 0.040 |
Why?
| | Brain Stem Neoplasms | 1 | 2020 | 89 | 0.040 |
Why?
| | Astrocytoma | 1 | 2020 | 120 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 579 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 54 | 0.040 |
Why?
| | Azepines | 1 | 2019 | 88 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 500 | 0.040 |
Why?
| | Lysine | 1 | 2020 | 278 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2019 | 129 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2002 | 731 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2024 | 1398 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1669 | 0.040 |
Why?
| | Triazoles | 1 | 2019 | 151 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 811 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1631 | 0.030 |
Why?
| | Pregnancy | 1 | 2008 | 6297 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1922 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 616 | 0.030 |
Why?
| | Neural Stem Cells | 1 | 2016 | 137 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 799 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2020 | 2069 | 0.030 |
Why?
| | Dacarbazine | 1 | 2014 | 97 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2014 | 182 | 0.030 |
Why?
| | Tumor Burden | 1 | 2014 | 282 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 326 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 162 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2020 | 1883 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 480 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 421 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4392 | 0.020 |
Why?
| | Alveolar Process | 1 | 2009 | 5 | 0.020 |
Why?
| | Dental Pulp | 1 | 2009 | 4 | 0.020 |
Why?
| | Tooth Root | 1 | 2009 | 13 | 0.020 |
Why?
| | Orthodontic Appliances | 1 | 2009 | 11 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10163 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1943 | 0.020 |
Why?
| | Receptor, trkA | 1 | 2009 | 16 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3692 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1681 | 0.020 |
Why?
| | Receptors, Growth Factor | 1 | 2009 | 46 | 0.020 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2009 | 39 | 0.020 |
Why?
| | Nerve Fibers | 1 | 2009 | 87 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 346 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 3780 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2618 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 10373 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2009 | 567 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2004 | 42 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2004 | 78 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2245 | 0.010 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2004 | 130 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5168 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1178 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 2674 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4008 | 0.010 |
Why?
| | Cytokines | 1 | 2004 | 1985 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 3050 | 0.010 |
Why?
|
|
Pierce's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|